Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer

NCT03740191 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Recuitment target for patient enrollment was not met.

Conditions

Low Risk Prostate Cancer
Intermediate Risk Prostate Cancer

Interventions

OTHER: EPIC questionnaire
RADIATION: kV x-ray images
RADIATION: Conebeam CT

Sponsor

EBG MedAustron GmbH